Current Board News: Platform
EPIC EMR Expedited Implementation Puts Clinical Research on the Fast-track
February 1, 2024
BEK worked with a major hospital network to quickly and collaboratively implement our EPIC compatible EMR Patient-Matching platform to set them up for streamlined feasibility and patient identification for ongoing clinical research.
Rapid Identification of Right-Fit Patients
February 1, 2024
A global pharmaceutical company needed to identify clinical research sites with the right patient population to enroll in a major depressive disorder (MDD) clinical trial. BEK rapidly identified several hundred right-fit patients at one clinical research site, toward the end of enrollment. This site would ultimately become the highest enrolling out of 57 clinical research sites.
Rapidly Find and Match Clinically Qualified Patients to Clinical Research Studies
January 26, 2024
BEK enables you to streamline trial and site network analysis within minutes providing researchers with realtime data to inform the decision-making process leading to improved patient matching and more successful trials.
Empowering Healthcare Organizations of all Sizes to Rapidly Find and Match Patients to Clinical Research Studies
January 26, 2024
BEK leverages a team of clinical experts and harnesses the power of AI to rapidly enhance your ability to find and match patients to clinical research studies.
BEKhealth uses AI to address the historical underrepresentation of women in clinical trials
March 25, 2023
March is Women’s History Month, a time to celebrate the contributions of women throughout history and acknowledge the challenges they have faced. One area where women have been historically underserved is in the clinical trial space.
BEKhealth Unveils Range of Enhancements Across the Platform to Improve Speed and Functionality
January 10, 2023
Following a year marked by the clinical research industry’s continued embrace and adoption of technology to advance and accelerate research processes, BEKhealth begins a new year by introducing several feature enhancements and technical upgrades intended to improve user experience and enable onsite clinical research coordinators along with pharmaceutical research sponsors to get the most value from the platform.
BEKhealth Concludes Prosperous 2022 Marked with New Customers, Partners, and Continued Innovation of its Clinical Research Platform
December 22, 2022
2022 was a banner year of growth and progress for BEKhealth and the broader adoption of its clinical research platform as evidenced by the addition of new customers, partnerships, and a significant expansion of the BEKhealth team.
Science 37 and BEKhealth Collaborate to Expand Patient Access via Community Providers
November 23, 2022
Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, and BEKhealth, a leading clinical research platform, today announced a partnership that will enable Science 37 to access the EMR data, exclusively, across its network of more than 35,000 community providers, covering more than 35 million patient lives–expanding participant access, accelerating enrollment, and potentially reducing time to market for important investigational treatments and therapies.
Curebase to Leverage BEKhealth’s Integrated Clinical Research Platform to More Easily Find and Recruit Decentralized Trial Participants, Expand into Oncology and New Therapeutic Areas
November 15, 2022
Curebase, a company dedicated to democratizing clinical trials through a decentralized model, today announced a partnership with BEKhealth, a clinical research operating platform, to dramatically expand patient access to decentralized clinical trials and enable research sponsors to find trial candidates with greater speed and efficiency.
Five Questions with BEKhealth Founder, Jason Baumgartner
November 3, 2022
In our latest blog, Jason discusses the impetus for starting BEKhealth, the company’s overarching mission, and the role he hopes BEKhealth will play in improving access to clinical research for larger portions of the population and accelerating approval of new life enhancing medicines.